EX-10.1 2 amrn-ex101_224.htm EX-10.1

EXHIBIT 10.1

AMARIN PHARMA INC .

Amarin Pharma Inc.

1430 Route 206, Suite 200

Bedminster, NJ 07921

Tel: 908-719-1315 Fa x: 908-7 1 9-3012

April 20, 2018

Mr. Aaron D. Berg 13 Country Place

Lebanon, NJ 08833 Dear Aaron:

This l ette r agreement (this "Agreement") follows up on our recent discussions regarding your continued employment with Amarin Corporation plc (the "Company"). As yo u know, the Company desires to continue your employment pursuant to the term s set forth below. Except with respect to the Restrictive Covenants Agreement and the Equity Documents, and subject to Section 15 below, this Agreement supersedes in all respects all prior agreements b etwee n you and the Company regarding the s ubject matter herein, including without limitati on any offer letter, employment agreement, or severa nce agreement. With those understandings, you and the Company agree as follows:

1.Position: You shall continue to serve as Senior Vice President. In addition, you shall serve as the Company's Chief Commercia l Officer. In such capacity, you will be responsible for Sales, Marketing, and Managed Care. You shall devote your full working time and efforts to the business and affairs of the Company. It is understood and agreed that, while you render serv ice s to the Company, you will not engage in any other employment, consulting or other bu si ne ss activities (whether full-time or part-time). Notw ith stan ding the foregoing, you may engage in religious, charitable, or other community activities so long as such services or activities do not interfere or conflict with your obligations to the Company. In addition to your role as Senior Vice President and Chief Commercial Officer of the Company, you acknowledge and agree that you may be required, without additional compensation, to perform duties for certa in affiliated entities of the Company, including without limitation Amarin Pharma, Inc., and to accept any reasonable office or position with any such affiliate as the Company's Board of Directors may require, including, but not limited to, service as an officer or director of any such affiliate.

2.Work Location: Your principal place of emp loyment will contin u e to be the Company's offices, which are currently located in Bedminster, New Jersey, subject to business travel requirements.

3.Salary: The Company will pay you a salary at the ann ual rate of $424,400, subject to periodic review and adjustment at the discretion of the Company. Currently o ur policy is to make sa lary payments semi-monthly.

1

EXHIBIT 10.1

4.Annual Bonus: Under th e Company' s mana ge ment incentive compensation program, you w ill be eligible to earn annual performance bonuses. The Company will target the

bonus of up to 40% of your annual salary rate. The actual bonus is discretionary and will be subject to the Company's assessment of your performance, as well as business conditions at the Company. The bonus also will be subject to your employment for the full period covered by the bonus, approval by and adjustment at the discretion of the Company's Board of Directors or an authorized committee thereof, and the terms of any applicable bonus plan. The Company may

also make adjustments in the targeted amount of your annual performance bonus. Any bonus awarded to you will be paid by March 15 of the year following the bonu s year to which such bonus relate s.

5.Benefits: You will continue to be eligible to participate in the employee benefits and insurance programs generally made available to the Company's full-time employee s, including health, life, disabilit y and dental insuranc e. You will be eligible for up t o 18 days of paid time off ("PTO") or such other amount determined by the Company, which shall accrue and in other respects be administered in accordance with the Company's policy from time to time. You will be reimbur s ed for all reasonable business expenses you incur while carrying out your duties on behalf of the Company; provided such reimbursement shall be conditioned on you following the Company's reimbursement policies and claims procedure, including by providing reasonable documentation of such expenses.

6.Equity: You shall continue to vest in your outstanding stock options, restricted stock or other equity incentive awards, subject to the terms of the Company's 2011 Stock Incentive Plan (the "Plan"), as may be amended from time to time, and any associated s tock option, restricted stock, and/or other equity incentive agreements (collectively, th e "Equity Documents"). Notwithstanding anything to the contrary in the Equity Documents, Section 7 of this Agreement shall control with respect to any of your equity interests that are unvested as of the Date of Termination, provided further, nothing herein shall be construed to be less favorable to you than the terms of the Equity Documents.

7.At-will Employment, Accrued Obligations; Severance: Your employment s hall continue to be “at will,” meaning you or the Company may terminate it at any time for any or no reason. In the event of the termination of your employment for any reason, the Company shall pay you the Accrued Obligations, defined as (1) your base salary through the date of termination, (2) an amount equal to the value of your accrued unused paid time off days, if any, and (3) the amount of any business expenses properly incurred by you on behalf of the Company prior to any such termination and not yet reimbursed, if any, within ten (10) days of the last day of your employment ("Date of Termination"). In addition to the Accrued Obligations, in the event the Company terminate s your employment without Cause at any time, or during the twent y-four (24) month period that immediately follows a Change of Control (the "Post-Change in Control Period") the Company terminates your employment without Cause or you terminate your employment for Good Reason (defined below), the Company shall provide you with the following termination benefits (the "Termination Benefits"), depending on the Date of Termination:

| (i) | continuation of your base s alary then in effect during the "Salary Continuation Period" which shall be either: (A) six (6) months from the Date of Termination, if the Company terminates your employment without Cause and the Date of |

2

EXHIBIT 10.1

Te rm ination occurs at any time outside of the Po st-Change in Control Period, or

(B) twelve (12) months from the Date of Termination, if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occur s during the Post-Change in Control Period. Solely for purposes of Section 409A of the Internal Revenue Code of 1986, as amended, each "Salary Continuation Payment" during the Salary Continuation Period is considered a separate payment;

| (ii) | continuation of group health plan benefits to the extent authorized by and consistent with 29 U.S.C. § 1161 et s eq. (commonly known as "COBRA"), with the cost of the regular premium for such benefit s shared in the same relative proportion by the Company and you as in effect on the Date of Termination until the earlier of: (i) the end of the Salary Continuation Period, and (ii) the date you become eligible for health benefits through another employer or otherwi s e become ineligible for COBRA; |

| (iii) | if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occurs during the Post-Change in Control Period, a lump sum cash payment equal to your target annual performance bonus for the year during which the Date of Termination occurs; |

| (iv) | if the Company terminates your employment without Cause and the Date of Termination occurs outside of the Post-Change in Control Period, six (6) month s of accelerated vesting from the Date of Termination with respect to any of your then outstanding stock options, restricted stock units or other equity incentive awards (in each case, only to the extent subject to time-based vesting); and |

| (v) | if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occurs during the Post-Change in Control Period, then outstanding stock options, restricted stock units or other equity incentive awards (whether or not subject to time based vesting) shall immediately vest in full effective upon the Date of Termination. |

Notwithstanding anything to the contrary in this Agreement, you shall not be entitled to any Termination Benefits unless you first (i) enter into, do not revoke, and comply with the terms of a separation agreement in a form acceptable to the Company which shall include a release of claims against the Company and related persons and entities (the "Release"), provided that the Release shall not require you to release (a) claims to enforce your right to receive Termination Benefits; (b) claims for vested benefits pursuant to ERJSA; (c) claims with respect to your vested equity rights as of the Date of Termination; (d) claims to enforce the Company's obligation to indemnify you to the extent such indemnification obligations exist; and (e) claims which legally may not be waived; (ii) resign from any and all positions, including, without implication of

3

EXHIBIT 10.1

limitation, as a director, trustee, an d office r, that you then hold wit h the Compan y an d any affiliate of the Company; and (iii) return all Company property and comply with any instructions related to deleting and purging duplicates of such Company property, in each case within the time period designated by the Company but in no event later than 60 days of the Date of Termination. The Salary Continuation Payments shall commence within 60 days after the Date of Termination and shall be made on the Company's regular payroll dates; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, the Salary Continuation Payments shall begin to be paid in the second calendar year. In the event you miss a regular payroll period between the Date of Termination and first Salary Continuation Payment, the first Salary Continuation Payment shall include a "catch up" payment.

Notwithstanding the foregoing, if you breach any of the material provisions of this Agreement or the Restrictive Covenants Agreement, in addition to all other rights and remedies, the Company shall have the right to terminate or cease payment of the Termination Benefits. For the avoidance of doubt, you shall not be entitled to the Termination Benefits in the event your employment ends due to your death or disability.

8.Definitions: For purposes of this Agreement, the following terms shall have the following meanings:

"Cause" shall mean: (i) conduct by you constituting an act of material misconduct in connection with the performance of your duties, including, without limitation, misappropriation of funds or property of the Company other than the occasional, customary and de minimis use of Company property for personal purposes; (ii) the commission by you of (A) any felony; or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii) any conduct by you that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries and affiliates if you were retained; (iv) continued non-performance or continued unsatisfactory performance by you of your responsibilities as reasonably determined by the Company's Board of Directors; (v) a breach by you of any of the material provisions of any agreement between you and the Company including, without limitation, any agreement relating to non-disclosure, non-competition or assignment of inventions; (vi) a material violation by you of any of the Company's written policies or procedures provided that, other than in the case of noncurable events, you are provided with written notice and fifteen (15) days to cure.

The meaning of "Change of Control" shall be limited to the following events, but only to the extent such events constitute a "change in the ownership or effective control" of the Company or a "change in the ownership of a substantial portion of the Company's assets" for purposes of Section 409A of the Code:

| (i) | any person or company (either alone or together with any person or company acting in concert with him or it) (an "Acquiring Company") obtaining Control of the Company, |

| (ii) | any person or company that Controls the Company becoming bound or entitled to acquire Shares under sections 974 to 991 of the UK Companies Act 2006, |

| (iii) | any court sanctioning a compromise or arrangement under section 899 of the UK Companies Act 2006, |

4

EXHIBIT 10.1

| (iv) | a resolution being tabled for the voluntary winding-up of the Company,

| (v) | any Acquiring Company acquiring all or substantially all of the assets of the Company, |

| (vi) | any merger, reorganization, consolidation or other similar transaction pursuant to which the holders of the Company's outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the Company or any resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction, |

| (vii) | the sale of all or a majority of the Shares of the Company to an unrelated person, entity or group thereof acting in concert, or |

| (viii) | any other similar transaction which the Board determines should constitute a Change of Control for the purposes of the Plan. |

"Control" shall mean the ownership of more than fifty (50) percent of the issued share capital or other equity interest of the Company or the legal power to direct or cause the direction of the general management and policies of the Company.

"Good Reason" shall mean that you have complied with "Good Reason Process" (hereinafter defined) following the occurrence of any of the following Good Reason conditions that occur without your consent: (i) a material diminution of your base salary; (ii) a material diminution in your authority, duties or responsibilities; (iii) a material change in the principal location where you are required to provide services for the Company (not including business travel and short term assignments); and/or (iv) a material breach by the Company of this Agreement. For purposes of this Agreement, "Good Reason Process" shall mean that: (x) you reasonably determine in good faith that a "Good Reason" condition has occurred; (y) you notify the Company in writing of the Good Reason condition within thirty (30) days of the first occurrence of such condition; (z) you cooperate in good faith with the Company's efforts, for a period of thirty (30) days following such notice (the "Cure Period"), to remedy the condition; notwithstanding such efforts, the Good Reason condition continues to exist; and you terminate your employment within thirty (30) days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

9.Section 280G Limitation: Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Company to or for the benefit of you, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 2800 of the Code and the applicable regulations thereunder (the "Severance Payments"), would be subject to the excise tax imposed by Section 4999 of the Code, the following provisions shall apply:

5

EXHIBIT 10.1

(a)If the Severance Payments, reduced by the sum of (1) the Excise Tax and (2) the total of the Federal, state, and local income and employment taxes payable by you on the amount of the Severance Payments which are in excess of the Threshold Amount, are greater than or equal to the Threshold Amount, you shall be entitled to the full benefits payable under this Agreement.

| (b) | If the Threshold Amount is less than (x) the Severance Payments, but greater than

(y)the Severance Payments reduced by the sum of (1) the Excise Tax and (2) the total of the Federal, state, and local income and employment taxes on the amount of the Severance Payments which are in excess of the Threshold Amount, then the Severance Payments shall be reduced (but not below zero) to the extent necessary so that the sum of all Severance Payments shall not exceed the Threshold Amount. In such event, the Severance Payments shall be reduced in the following order: (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non cash forms of benefits. To the extent any payment is to be made over time (e.g., in installments, etc.), then the payments shall be reduced in reverse chronological order.

(c)For the purposes of this Section, "Threshold Amount" shall mean three times your "base amount" within the meaning of Section 280G(b)(3) of the Code and the regulations promulgated thereunder less one dollar ($1.00); and "Excise Tax" shall mean the excise tax imposed by Section 4999 of the Code, and any interest or penalties incurred by you with respect to such excise tax.

(d)The determination as to which of the alternative provisions of this Section 10 shall apply to you shall be made by a nationally recognized accounting firm selected by the Company (the "Accounting Firm"), which shall provide detailed supporting calculations both to the Company and you within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or you. For purposes of determining which of the alternative provisions of this Section 10 shall apply, you shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in the state and locality of your residence on the date of termination, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. Any determination by the Accounting Firm shall be binding upon the Company and you.

10.Taxes; Section 409A: All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholdings and payroll taxes and other deductions required by law. You hereby acknowledge that the Company does not have a duty to design its compensation policies in a manner that minimizes tax liabilities. Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service within the meaning of Section 409A of the Code, the Company determines that you are a "specified employee" within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this Agreement on account of your separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section

6

EXHIBIT 10.1

409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one da y after your separation from service, or (B) your death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that wo uld otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original sc hedule.

All in-kind benefits provided and expenses eligible for reimbur sement under this Agreement sha ll be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbur seme nt s s hall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year s hall not affect the in-kind benefit s to be provided or the expenses eligible for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefit s is not su bject to liquidation or exchange for another benefit.

To the extent that any payment or benefit described in this Agreement constitutes "non-qualifi ed deferred compensation" under Section 409A of the Code, and to the extent that such payment or benefit is payable up on the termination of this Agreement, then such payments or benefits shall be payable only upon your "separation from serv ice." The det erminat ion of whether and when a separa tion from service has occurred sha ll be made in accordance with the presumpti ons set forth in Treasury Regulation Section l.409A-l(h).

The parties intend that this Agr eeme nt will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its comp liance with Section 409A of the Code, the provision s hall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be amended, as r easo nably reque ste d by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party.

The Company makes no representation or warranty and shall have no liability to you or any o ther person if any provisions of this Agreement are determined to constitu t e deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, suc h Section.

11.Restrictive Covenants Agreement: You acknowledge your continuing obligations under your Nondisclosure, Development s and Noncompetition Agreement dated November 19, 2012, which, among other things, prohibits disclosure of any confidential or proprietary information of the Company (the "Restrictive Covenants Agre eme nt"). A copy of the Restricti ve Covenants Agreement is attached as Exhibit A, and the terms are incorporated by reference as material terms of this Agreement.

12.Representation Regarding Other Obligations: You reaffirm that you are not subject to any confidentiality, non-competition agreement or any other similar type of restriction that may affect your ability to devote full time and attention to yo ur work at the Company. If you have entered into any agreement that may restrict your activities on behalf of the

7

EXHIBIT 10.1

Company, please provide me with a copy of the agreement as soon as possible.

13.Protected Disclosures: Nothing in this Agreement or the Restrictive Covenants Agreement shall be interpreted or applied to prohibit you from making any good faith report to any governmental agency or other governmental entity (a "Government Agency") concerning any act or omission that you reasonably believe constitutes a possible violation of federal or state law or making other disclosures that are protected under the anti-retaliation or whistleblower provisions of applicable federal or state law or regulation. In addition, nothing contained in this Agreement limits your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including your ability to provide documents or other information, without notice to the Company.

14.Other Terms: Your employment with the Company shall continue to be on an at- will basis. In other words, you or the Company may terminate employment for any reason and at any time, with or without notice, subject to the Termination Benefits provisions herein. Similarly, the terms of employment outlined in this Agreement are subject to change at any time. In addition, this Agreement is contingent on the completion of references checks and a background investigation that are satisfactory to the Company (as determined by the Company) and your submission of satisfactory proof of your identity and your legal authorization to work in the United States and a satisfactory Company paid initial-employment physical and drug screen, in each case to the extent not already completed.

15.Interpretation, Amendment and Enforcement: This Agreement, including the Restrictive Covenants Agreement and the Equity Documents, constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (whether written, oral or implied) between you and the Company with regard to this subject matter, provided that the Deed of Indemnity between the Company and you dated April 21, 2015 (the "Deed of Indemnity"), the Letter Agreement dated April _ , 2018, and the "Release of Claims" (as defined and preserved in the Letter Agreement) shall remain in full force and effect in accordance with their terms. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. The terms of this Agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this Agreement or arising out of, related to, or in any way connected with, this Agreement, your employment with

)

the Compan y or an y other relationship between you an d th e Compan y (th e “Dispute s”) wil l be

governed by the laws of the State of New Jersey, excluding laws relating to conflicts or choice of law. You and the Company submit to the exclusive personal jurisdiction of the federal and state courts located in the State of New Jersey in connection with any Dispute or any claim related to any Dispute.

16.Assignment: Neither you nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without your consent to one of its Affiliates or to any person with whom the Company shall hereafter effect a reorganization, consolidate with, or merge into or to whom

8

EXHIBIT 10.1

it transfers all or substantially all of its properties or assets. This Agreement shall inure to the benefit of and be binding upon you and the Company, and each of our respective successors, executors, administrators, heirs and permitted assigns.

We look forward to continuing to work with you at Amarin. If you have any questions about thi s information, please do not hesitate to call. Otherwise, please confirm your acceptance of this Agreement by signing below and returning a copy to me. This Agreement shall become effective on the date when it becomes fully executed (the "Effective Date"). PDF and facsimile signatures shall have the same legal effect as originals.

Signed for and on behalf of:

AMARIN CORPORATION PLC

Signed: | /s/ John F. Thero
Dated: | April 20, 2018

ACCEPTED:

Signed: | /s/ Aaron D. Berg
Name: | Aaron D. Berg
Dated: | May 17, 2018

9

Exhibit A

Nondisclosure , Developments and Noncompetition Agreement